Other
Flu Vaccine
0
Pipeline Programs↗
0
Active Trials↗
2
Companies Involved↗
Flu Vaccine is an early-stage landscape with 0 programs across 2 companies. The most active players are BiondVax Pharmaceuticals ltd., Folia Biotech Inc..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
20
clinical trials
Completed18 · 90%
Terminated1 · 5%
Unknown status1 · 5%
Clinical Trials
Trial Activity
20 trials
Safety Study of Avian Flu Vaccine
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT00408109·45 enrolled
Half-Dose Flu Vaccine Study in Healthy Adults
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00006146·840 enrolled
Flu Vaccine Study in Neuromuscular Patients 2011
Completed·—·Phase 4·NCT01422200·22 enrolled
Study of a Flu Vaccine in Children
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 3·NCT00001127·15,000 enrolled
Comparison of Delivery Routes of Flu Vaccine in Adults
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT00170547·1,597 enrolled
Comparison of Flu Vaccine Doses in Children
Completed·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 1·NCT01164553·243 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)